Excelsior Sciences
4 known investors
Excelsior Sciences develops automated chemistry technology for small-molecule discovery and manufacturing, targeting pharmaceutical and materials development. Its proprietary Blocc Chemistry platform uses AI-guided synthesis to accelerate drug discovery through machine-readable chemical building blocks and closed-loop learning.
Founders & leadership
MF
Michael FoleyCEO
JJ
Jana JensenCOO
MB
Marty Burke
BG
Bartosz Grzybowski